Association of TGFBR2 polymorphism with risk of sudden cardiac arrest in patients with coronary artery disease
Background
Transforming growth factor ß (TGFß) signaling has been shown to promote myocardial fibrosis and remodeling with coronary artery disease (CAD), and previous studies show a major role for fibrosis in the initiation of malignant ventricular arrhythmias (VA) and sudden cardiac arrest (SCA). Common single nucleotide polymorphisms (SNPs) in TGFß pathway genes may be associated with SCA.
Objective
We examined the association of common SNPs among 12 candidate genes in the TGFß pathway with the risk of SCA.
Methods
SNPs (n = 617) were genotyped in a case-control study comparing 89 patients with CAD and SCA caused by VA to 520 healthy control subjects.
Results
Nineteen SNPs among 5 genes (TGFB2, TGFBR2, SMAD1, SMAD3, SMAD6) were associated with SCA after adjustment for age and sex. After permutation analysis to account for multiple testing, a single SNP in TGFBR2 (rs9838682) was associated with SCA (odds ratio: 1.66, 95% confidence interval: 1.08 to 2.54, P = .02).
Conclusion
We show an association between a common TGFBR2 polymorphism and risk of SCA caused by VA in the setting of CAD. If validated, these findings support the role of genetic variation in TGFß signaling in SCA susceptibility.
Keywords: Sudden cardiac arrest, Ventricular tachycardia, Ventricular fibrillation, Coronary artery disease, Transforming growth factor ß, Genetics
Abbreviations: CAD, coronary artery disease, CI, confidence interval, LD, linkage disequilibrium, MI, myocardial infarction, OR, odds ratio, PCA, principal component analysis, SCA, sudden cardiac arrest, SCD, sudden cardiac death, SNP, single nucleotide polymorphism, TGF, transforming growth factor, VA, ventricular arrhythmia, VF, ventricular fibrillation, VT, ventricular tachycardia
To access this article, please choose from the options below
Funded by grants from the National Center for Research Resources, a component of the National Institutes of Health and the National Institutes of Health Roadmap for Medical Research (KL2 RR024130).
PII: S1547-5271(09)00935-7
doi:10.1016/j.hrthm.2009.08.031
© 2009 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.
